All updated as on -
The Organ Preservation Market Size, which was estimated at USD 0.9 billion in 2022, is anticipated to increase from USD 0.38 billion in 2023 to USD 0.59 billion by 2030, with a compound annual growth rate (CAGR) of 6.8% throughout the forecast period (2023 - 2030). The market for organ preservation is expanding as a result of increased organ failure rates globally, organ donor awareness efforts, an aging population, and the existence of significant players in both developing and developed countries. Just a handful of the major drivers that are influencing the market are listed above.
For instance, persufflation is a straightforward and promising preservation method that enhances oxygenation, which enhances grafting during conservation and protection, as well as transplantation. In order to deliver better healthcare services, governments all around the world are concentrating on bolstering their healthcare infrastructures. For instance, the Brihanmumbai Municipal Corporation (BMC) in India set aside over USD 924 million to enhance healthcare offerings and create 100 health clinics with more than 100 diagnostic tests for BMC regions.
The number of hospitals caring for patients who are brain dead and who might make potential donors will rise as a result of these infrastructure improvements. The shorter wait times for donor-recipient cross-matching, subject profiling, genetic testing, and other related diagnostic procedures prior to transplantation will also result from the increased number of testing laboratories. These developments are anticipated to expand the market for organ preservation.
One of the most frequent causes of death in ICUs is multiple organ failure, which is primarily brought on by sepsis. According to estimates from the Society of Critical Care Medicine, up to 20% of patients with sepsis exhibit acute respiratory failure, while between 26 and 50 percent of patients with sepsis suffer acute kidney failure. Acute renal failure is more common in the elderly due to age-related declines in renal plasma flow and glomerular filtration rate. These illnesses and numerous organ failures are both made more likely by diabetes. Geriatric patients are more likely to have illnesses including TB and liver cirrhosis, which may necessitate organ transplantation.
The number of organ transplant procedures performed has increased significantly as a result of the aging population, according to the Organ Procurement and Transplantation Network, as has the number of older patients receiving organ transplants. For instance, the number of organ transplants in the over-65 age category increased in the US from 8,691 in 2019 to 8,895 in 2021. According to the UN World Population Ageing Report, there were 728 million individuals in the world who were 65 or older in 2020; this number is predicted to reach 1.5 billion by 2050, indicating the possibility of rising demand. Due to this demographic segment's high sensitivity to illnesses that cause organ failure, its growth will be a major factor in the market's expansion (source: UN Department of Economic and Social Affairs).
Organ transplantation requires a lot of resources, including highly compensated doctors and surgeons, pricey transportation, and expensive medications. The whole cost is increased by the fees for inpatient treatment, organ procurement, preservation, post-operative recipient care, and anti-rejection drugs. For assessments or follow-ups arranged at the transplant center for an agreed-upon period of medical supervision, patients are also responsible for covering the costs of travel, housing, meals, hospital visits, and other medical tests. For patients with little financial resources, these costs immediately compete with spending on needs like food, clothes, and housing, making organ transplant treatments frequently unattainable without outside assistance. Organ transplantation is incredibly unequal, but governments might encourage more inexpensive therapies or offer financial assistance for expensive surgeries, especially for people with low incomes. As a result, one of the key challenges limiting the growth of the organ preservation market is the high cost of transplant procedures. Although China and India offer medical tourism, the cost of organ transplants there is far lower than in developed countries.
The global increase in organ transplant procedures and the increased frequency of multiple organ failure are the main factors driving the market's expansion. According to a 2019 Health Resources & Services Administration data, 36,528 organ transplants were carried out in the US in 2018, and 95.00% of the country's adults support organ donation. Out of a total of 17,553 donors recorded in 2018, it was further mentioned that 6,831 living donors and 10,722 deceased donors were reported. Additionally, a number of awareness campaigns are anticipated to have a positive impact on the sector. For example, the 12th of October is celebrated as European Day for Organ Donation and Transplantation. A 2019 report from the Council of Europe revealed that 41,000 individuals in Europe got organ transplants in 2018. As a result, it is anticipated that these events will promote the growth of the organ preservation sector during the future years. As a result, this element is fueling the market CAGR.
The rate of kidney transplants is expected to rise as chronic kidney diseases and cases of renal failure become more common. According to the Centers for Disease Control & Prevention (CDC), around 15.00% of American adults had chronic renal disease in 2019. In a similar vein, according to a 2019 report from the National Institute of Diabetes and Digestive and Kidney Diseases, about 661,000 Americans have kidney failure, of which 468,000 are receiving dialysis and over 193,000 have received kidney transplants. Therefore, it is anticipated that these factors will support the growth of the organ transplantation market throughout the upcoming years. It is so projected that this factor will accelerate global Organ Preservation market revenue.
Report Coverage
Global Organ Preservation research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Organ Preservation report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Organ Preservation competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Organ Preservation market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Organ Preservation market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Organ Preservation market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Bristol Myers Squibb, Artivion Inc, Accord Healthcare Limited, BioLife Solutions Inc, Lifeline Scientific, BioLifeSolutions, Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), and TX Innovations (Netherlands).
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Organ Preservation market based on the below-mentioned segments:
Global Organ Preservation Market, By Type
Kidney
Liver
Heart
Lungs
Global Organ Preservation market, By Techniques
Techniques Static Cold Storage
Dynamic Cold Storage
Global Organ Preservation Market, By End User
Hospitals & Clinics
Organ Banks
Global Organ Preservation market, Regional Analysis
For instance, persufflation is a straightforward and promising preservation method that enhances oxygenation, which enhances grafting during conservation and protection, as well as transplantation. In order to deliver better healthcare services, governments all around the world are concentrating on bolstering their healthcare infrastructures. For instance, the Brihanmumbai Municipal Corporation (BMC) in India set aside over USD 924 million to enhance healthcare offerings and create 100 health clinics with more than 100 diagnostic tests for BMC regions.
The number of hospitals caring for patients who are brain dead and who might make potential donors will rise as a result of these infrastructure improvements. The shorter wait times for donor-recipient cross-matching, subject profiling, genetic testing, and other related diagnostic procedures prior to transplantation will also result from the increased number of testing laboratories. These developments are anticipated to expand the market for organ preservation.
One of the most frequent causes of death in ICUs is multiple organ failure, which is primarily brought on by sepsis. According to estimates from the Society of Critical Care Medicine, up to 20% of patients with sepsis exhibit acute respiratory failure, while between 26 and 50 percent of patients with sepsis suffer acute kidney failure. Acute renal failure is more common in the elderly due to age-related declines in renal plasma flow and glomerular filtration rate. These illnesses and numerous organ failures are both made more likely by diabetes. Geriatric patients are more likely to have illnesses including TB and liver cirrhosis, which may necessitate organ transplantation.
The number of organ transplant procedures performed has increased significantly as a result of the aging population, according to the Organ Procurement and Transplantation Network, as has the number of older patients receiving organ transplants. For instance, the number of organ transplants in the over-65 age category increased in the US from 8,691 in 2019 to 8,895 in 2021. According to the UN World Population Ageing Report, there were 728 million individuals in the world who were 65 or older in 2020; this number is predicted to reach 1.5 billion by 2050, indicating the possibility of rising demand. Due to this demographic segment's high sensitivity to illnesses that cause organ failure, its growth will be a major factor in the market's expansion (source: UN Department of Economic and Social Affairs).
Organ transplantation requires a lot of resources, including highly compensated doctors and surgeons, pricey transportation, and expensive medications. The whole cost is increased by the fees for inpatient treatment, organ procurement, preservation, post-operative recipient care, and anti-rejection drugs. For assessments or follow-ups arranged at the transplant center for an agreed-upon period of medical supervision, patients are also responsible for covering the costs of travel, housing, meals, hospital visits, and other medical tests. For patients with little financial resources, these costs immediately compete with spending on needs like food, clothes, and housing, making organ transplant treatments frequently unattainable without outside assistance. Organ transplantation is incredibly unequal, but governments might encourage more inexpensive therapies or offer financial assistance for expensive surgeries, especially for people with low incomes. As a result, one of the key challenges limiting the growth of the organ preservation market is the high cost of transplant procedures. Although China and India offer medical tourism, the cost of organ transplants there is far lower than in developed countries.
The global increase in organ transplant procedures and the increased frequency of multiple organ failure are the main factors driving the market's expansion. According to a 2019 Health Resources & Services Administration data, 36,528 organ transplants were carried out in the US in 2018, and 95.00% of the country's adults support organ donation. Out of a total of 17,553 donors recorded in 2018, it was further mentioned that 6,831 living donors and 10,722 deceased donors were reported. Additionally, a number of awareness campaigns are anticipated to have a positive impact on the sector. For example, the 12th of October is celebrated as European Day for Organ Donation and Transplantation. A 2019 report from the Council of Europe revealed that 41,000 individuals in Europe got organ transplants in 2018. As a result, it is anticipated that these events will promote the growth of the organ preservation sector during the future years. As a result, this element is fueling the market CAGR.
The rate of kidney transplants is expected to rise as chronic kidney diseases and cases of renal failure become more common. According to the Centers for Disease Control & Prevention (CDC), around 15.00% of American adults had chronic renal disease in 2019. In a similar vein, according to a 2019 report from the National Institute of Diabetes and Digestive and Kidney Diseases, about 661,000 Americans have kidney failure, of which 468,000 are receiving dialysis and over 193,000 have received kidney transplants. Therefore, it is anticipated that these factors will support the growth of the organ transplantation market throughout the upcoming years. It is so projected that this factor will accelerate global Organ Preservation market revenue.
Report Coverage
Global Organ Preservation research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Organ Preservation report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Organ Preservation competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Organ Preservation market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Bristol Myers Squibb, Artivion Inc, Accord Healthcare Limited, BioLife Solutions Inc, Lifeline Scientific, BioLifeSolutions, Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), and TX Innovations (Netherlands). |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Organ Preservation Market from 2021 to 2030.
- Market Forecast for Organ Preservation Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Organ Preservation competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Organ Preservation
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Organ Preservation market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Organ Preservation market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Bristol Myers Squibb, Artivion Inc, Accord Healthcare Limited, BioLife Solutions Inc, Lifeline Scientific, BioLifeSolutions, Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals, LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), and TX Innovations (Netherlands).
Primary Target Market
- Market Players of Organ Preservation
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Organ Preservation market based on the below-mentioned segments:
Global Organ Preservation Market, By Type
Kidney
Liver
Heart
Lungs
Global Organ Preservation market, By Techniques
Techniques Static Cold Storage
Dynamic Cold Storage
Global Organ Preservation Market, By End User
Hospitals & Clinics
Organ Banks
Global Organ Preservation market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive organ preservation market market research and competitor analysis for your business to help you develop more profound insights into the organ preservation market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the organ preservation market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.